Empowers people to achieve their future credit score before borrowing
Post-money valuation ⓘ
$151.8M
As of Mar 2024 · from Reg CF Offering (2023) · pre-money + amount raised, not a traded price
Total raised
$782,598
Across 2 rounds since 2023
Latest share price
$0.12
Reg CF Offering (2025) offering price
Financials
FY2021–FY2025 · from SEC filings · hover any figure for its source
$67.7M
$6.4M
2021
$70.7M
$1.1M
2022
$84.4M
$632K
2023
$93.4M
$1.6M
2024
$128.6M
−$6.7M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$67,725,114
$70,658,606
$84,355,223
$93,371,218
$128,625,869
Cost of goods sold
$8,526,328
$8,205,508
$9,992,271
$18,247,290
$23,260,183
Gross margin
87%
88%
88%
80%
82%
Net income
$6,354,458
$1,147,275
$631,888
$1,576,727
-$6,683,922
Taxes paid
$2,082,681
$800
$471,483
$140,826
$12,800
Balance sheet
Cash
$4,004,838
$5,074,371
$1,770,202
$4,540,908
$4,794,497
Accounts receivable
$0
$1,792,946
$2,032,921
$1,462,594
$1,309,967
Total assets
$17,849,046
$26,100,567
$24,547,441
$29,816,523
$45,737,487
Short-term debt
$0
$0
$13,435,464
$1,999,493
$553,671
Long-term debt
$0
$12,000,000
$12,765,082
$10,403,636
$10,749,115
Total liabilities
$0
$12,000,000
$26,200,546
$12,403,129
$11,302,786
Other
Headcount
—
116
102
100
117
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.